Workshop summary: health outcomes and health economic issues surrounding the use of biological therapies in patients with rheumatoid arthritis.
Maini
R N
RN
Kennedy International Institute of Rheumatology, London, UK.
Wolfe
F
F
D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000191:economics*; D017048:Health Care Costs; D006801:Humans; D016896:Treatment Outcome